Gene hunt: could your DNA predict clot danger after hip or knee surgery?
NCT ID NCT03275610
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to find genetic markers that may increase the risk of a pulmonary embolism (a blood clot in the lung) after hip or knee replacement surgery. Researchers will collect blood samples from 100 adults who have had a clot after such surgery and analyze their DNA. The goal is to use this information in the future to better identify patients at risk, potentially reducing bleeding complications while preventing clots.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY EMBOLISM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Southern California
Los Angeles, California, 90033, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new exercise plan aims to get pulmonary embolism survivors back on their feet
- Spotting hidden blood clots in scarred lungs: a study hunts for clues
- Decades-Long study of 121,700 nurses aims to uncover hidden heart disease triggers
- Massive chest pain registry reveals gaps between guidelines and real-world care in china
- New catheter aims to treat dangerous blood clots in the lungs without ICU stay
- Timing of blood thinners after childbirth bleeding may prevent clots without causing more harm